|
CA1314870C
(fr)
*
|
1983-08-02 |
1993-03-23 |
Arthur G. Schwartz |
Steroides utilises comme agents contre le cancer, l'obesite, l'hyperglycemie, l'auto-immunite et l'hypercholesterolemie
|
|
US5804576A
(en)
*
|
1983-08-02 |
1998-09-08 |
Research Corporation Technologies, Inc. |
Derivatives of 5-androsten-17-ones and 5-androstan-17-ones
|
|
US5656621A
(en)
*
|
1983-08-02 |
1997-08-12 |
Research Corporation Tech., Inc. |
Steroids useful as anti-cancer and anti-obesity agents
|
|
US5714481A
(en)
*
|
1983-08-02 |
1998-02-03 |
Research Corporation Technologies, Inc. |
Derivatives of 5-androsten-17 ones and 5-androstan-17-ones
|
|
US5175154A
(en)
*
|
1987-11-25 |
1992-12-29 |
Research Corporation Technologies, Inc. |
5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
|
|
US5028631A
(en)
*
|
1987-11-25 |
1991-07-02 |
Schwartz Arthur G |
Homoandrostan-17-one and homoandrosten-17-ones
|
|
US4898694A
(en)
*
|
1987-11-25 |
1990-02-06 |
Schwartz Arthur G |
17-Hydroxy-steroids
|
|
US5001119A
(en)
*
|
1987-11-25 |
1991-03-19 |
Schwartz Arthur G |
16-substituted androstanes and 16-substituted androstenes
|
|
DE60045751D1
(de)
|
1999-09-30 |
2011-04-28 |
Harbor Biosciences Inc |
Therapeutische Behandlung androgenrezeptorbedingter Leiden
|
|
CA3152410A1
(en)
|
2011-10-14 |
2013-04-18 |
Sage Therapeutics, Inc. |
3,3-disubstituted 19-nor pregnane compounds, compositions, and uses thereof for the treatment of cns related disorders
|
|
SMT202000008T1
(it)
|
2012-01-23 |
2020-03-13 |
Sage Therapeutics Inc |
Formulazione di steroide neuroattivo comprendente un complesso di allopregnanolone e solfobutil eter beta-ciclodestrina
|
|
PL2887944T3
(pl)
|
2012-08-21 |
2022-02-21 |
Sage Therapeutics, Inc. |
Allopregnanolon do leczenia lekoopornego stanu padaczkowego
|
|
WO2014169831A1
(fr)
|
2013-04-17 |
2014-10-23 |
Sage Therapeutics, Inc. |
19-nor-hétéroaryl-stéroïdes c21-c-liés c3,3-disubstitués et procédés d'utilisation de ceux-ci
|
|
CN113527400B
(zh)
|
2013-04-17 |
2024-06-28 |
萨奇治疗股份有限公司 |
19-去甲c3,3-二取代的c21-n-吡唑基类固醇及其使用方法
|
|
US20160068563A1
(en)
|
2013-04-17 |
2016-03-10 |
Boyd L. Harrison |
19-nor neuroactive steroids and methods of use thereof
|
|
RU2019126333A
(ru)
|
2013-04-17 |
2019-10-08 |
Сейдж Терапьютикс, Инк. |
19-нор нейроактивные стероиды и способы их применения
|
|
WO2015010054A2
(fr)
|
2013-07-19 |
2015-01-22 |
Sage Therapeutics, Inc. |
Stéroïdes neuroactifs, compositions, et leurs utilisations
|
|
AU2014308621C1
(en)
|
2013-08-23 |
2022-01-06 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
WO2015195962A1
(fr)
|
2014-06-18 |
2015-12-23 |
Sage Therapeutics, Inc. |
Stéroïdes neuroactifs, leurs compositions et utilisations
|
|
JOP20200195A1
(ar)
|
2014-09-08 |
2017-06-16 |
Sage Therapeutics Inc |
سترويدات وتركيبات نشطة عصبياً، واستخداماتها
|
|
SMT202000414T1
(it)
|
2014-10-16 |
2020-09-10 |
Sage Therapeutics Inc |
Composizioni e metodi per trattare disturbi del snc
|
|
MX2021004492A
(es)
|
2014-10-16 |
2022-12-05 |
Sage Therapeutics Inc |
Composiciones para el tratamiento de trastornos del snc.
|
|
ME03749B
(fr)
|
2014-11-27 |
2021-04-20 |
Sage Therapeutics Inc |
Compositions et procédés pour traiter des troubles du snc
|
|
DK3250210T3
(da)
|
2015-01-26 |
2021-03-08 |
Sage Therapeutics Inc |
Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
|
|
JP6875996B2
(ja)
|
2015-02-20 |
2021-05-26 |
セージ セラピューティクス， インコーポレイテッド |
神経刺激性ステロイド、組成物、およびその使用
|
|
RU2766155C2
(ru)
|
2016-03-08 |
2022-02-08 |
Сейдж Терапьютикс, Инк. |
Нейроактивные стероиды, их композиции и применения
|
|
WO2018013613A1
(fr)
|
2016-07-11 |
2018-01-18 |
Sage Therapeutics, Inc. |
Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
|
|
CA3030420C
(fr)
|
2016-07-11 |
2025-11-18 |
Sage Therapeutics, Inc. |
Steroides neuroactifs substitues en c7, c12 et c16 et methodes d'utilisation associees
|
|
CN114206900A
(zh)
|
2019-05-31 |
2022-03-18 |
萨奇治疗股份有限公司 |
神经活性类固醇及其组合物
|